AU2149797A - Therapeutic agents for asthma - Google Patents
Therapeutic agents for asthmaInfo
- Publication number
- AU2149797A AU2149797A AU21497/97A AU2149797A AU2149797A AU 2149797 A AU2149797 A AU 2149797A AU 21497/97 A AU21497/97 A AU 21497/97A AU 2149797 A AU2149797 A AU 2149797A AU 2149797 A AU2149797 A AU 2149797A
- Authority
- AU
- Australia
- Prior art keywords
- agent
- asthma
- therapeutic agents
- safely
- immediate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Abstract
The description relates to a therapeutic agent which comprises as the active agent a compound given by the formula (1) and/or (1') and/or a pharmaceutically acceptable salt thereof. The agent of the invention exhibits great effectiveness in cases of both immediate and later asthmatic reactions, especially the latter. Owing to its low toxicity, the agent of the invention can safely be prescribed for human beings.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8-11848 | 1996-01-26 | ||
JP1184896 | 1996-01-26 | ||
PCT/DE1997/000135 WO1997026968A2 (en) | 1996-01-26 | 1997-01-27 | Therapeutic anti-asthma agents containing selenium compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2149797A true AU2149797A (en) | 1997-08-20 |
AU728713B2 AU728713B2 (en) | 2001-01-18 |
Family
ID=11789151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21497/97A Ceased AU728713B2 (en) | 1996-01-26 | 1997-01-27 | Therapeutic agents for asthma |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0876144B1 (en) |
CN (1) | CN1116876C (en) |
AT (1) | ATE207746T1 (en) |
AU (1) | AU728713B2 (en) |
BR (1) | BR9707303A (en) |
CA (1) | CA2244085C (en) |
CZ (1) | CZ292670B6 (en) |
DE (2) | DE19780042D2 (en) |
DK (1) | DK0876144T3 (en) |
EA (1) | EA001066B1 (en) |
ES (1) | ES2165034T3 (en) |
HK (1) | HK1019862A1 (en) |
HU (1) | HUP9901639A3 (en) |
IL (1) | IL124006A (en) |
NO (1) | NO983217L (en) |
NZ (1) | NZ330198A (en) |
PL (1) | PL187620B1 (en) |
PT (1) | PT876144E (en) |
TR (1) | TR199801398T2 (en) |
WO (1) | WO1997026968A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7671211B1 (en) | 1999-03-31 | 2010-03-02 | Arne Holmgren | Substrates for thioredoxin reductase |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000016935A (en) * | 1998-07-01 | 2000-01-18 | Dai Ichi Seiyaku Co Ltd | Cyclooxygenase inhibitor |
EP2409977A4 (en) | 2009-03-17 | 2012-09-26 | Daiichi Sankyo Co Ltd | Amide derivative |
US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
CN105622478B (en) * | 2014-10-27 | 2017-08-25 | 中国科学院大连化学物理研究所 | The ketone derivatives of 3,3 2 alkylthio group, 2 phenylseleno, 2 propylene 1 and synthesis |
CN109627198B (en) * | 2019-02-01 | 2020-11-10 | 河南科技大学 | 2-acetonyl selenium-based benzamide compound and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778814A (en) * | 1987-03-18 | 1988-10-18 | Ciba-Geigy Corporation | Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one |
DZ1460A1 (en) * | 1989-11-22 | 2004-09-13 | Sod Conseils Rech Applic | New selenophen derivatives and their preparation process. |
IT1250751B (en) * | 1991-08-02 | 1995-04-21 | Boehringer Mannheim Italia | (3H, 7H) SELENAZOLO (3,4-A | PYRIDIN WITH ANTIASMATIC AND ANTIINFLAMMATORY ACTIVITIES OF THE AERIAL ROUTES |
JP2553434B2 (en) * | 1992-04-28 | 1996-11-13 | 第一製薬株式会社 | Granular formulation |
JPH07233056A (en) * | 1993-09-03 | 1995-09-05 | Dai Ichi Seiyaku Co Ltd | Lipoxygenase inhibitor |
DE19506669A1 (en) * | 1995-02-25 | 1996-08-29 | Nattermann A & Cie | Lipoxygenase inhibitor for treating asthma, tumours, shock etc. |
-
1997
- 1997-01-27 CZ CZ19982356A patent/CZ292670B6/en not_active IP Right Cessation
- 1997-01-27 ES ES97914084T patent/ES2165034T3/en not_active Expired - Lifetime
- 1997-01-27 EA EA199800658A patent/EA001066B1/en not_active IP Right Cessation
- 1997-01-27 CA CA002244085A patent/CA2244085C/en not_active Expired - Fee Related
- 1997-01-27 AU AU21497/97A patent/AU728713B2/en not_active Ceased
- 1997-01-27 WO PCT/DE1997/000135 patent/WO1997026968A2/en active IP Right Grant
- 1997-01-27 EP EP97914084A patent/EP0876144B1/en not_active Expired - Lifetime
- 1997-01-27 DE DE19780042T patent/DE19780042D2/en not_active Ceased
- 1997-01-27 DE DE59705183T patent/DE59705183D1/en not_active Expired - Lifetime
- 1997-01-27 BR BR9707303-2A patent/BR9707303A/en not_active Application Discontinuation
- 1997-01-27 AT AT97914084T patent/ATE207746T1/en not_active IP Right Cessation
- 1997-01-27 CN CN97191886A patent/CN1116876C/en not_active Expired - Fee Related
- 1997-01-27 HU HU9901639A patent/HUP9901639A3/en unknown
- 1997-01-27 PL PL97328198A patent/PL187620B1/en not_active IP Right Cessation
- 1997-01-27 DK DK97914084T patent/DK0876144T3/en active
- 1997-01-27 PT PT97914084T patent/PT876144E/en unknown
- 1997-01-27 NZ NZ330198A patent/NZ330198A/en unknown
- 1997-01-27 TR TR1998/01398T patent/TR199801398T2/en unknown
- 1997-01-27 IL IL12400697A patent/IL124006A/en not_active IP Right Cessation
-
1998
- 1998-07-13 NO NO983217A patent/NO983217L/en not_active Application Discontinuation
-
1999
- 1999-11-03 HK HK99104998A patent/HK1019862A1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7671211B1 (en) | 1999-03-31 | 2010-03-02 | Arne Holmgren | Substrates for thioredoxin reductase |
Also Published As
Publication number | Publication date |
---|---|
CN1219127A (en) | 1999-06-09 |
CZ235698A3 (en) | 1999-04-14 |
HK1019862A1 (en) | 2000-03-03 |
PL187620B1 (en) | 2004-08-31 |
EP0876144B1 (en) | 2001-10-31 |
WO1997026968A2 (en) | 1997-07-31 |
HUP9901639A1 (en) | 1999-09-28 |
EP0876144A2 (en) | 1998-11-11 |
WO1997026968A3 (en) | 1997-09-25 |
DE59705183D1 (en) | 2001-12-06 |
IL124006A (en) | 2004-07-25 |
DK0876144T3 (en) | 2002-02-25 |
CA2244085A1 (en) | 1997-07-31 |
CN1116876C (en) | 2003-08-06 |
ATE207746T1 (en) | 2001-11-15 |
EA199800658A1 (en) | 1999-02-25 |
AU728713B2 (en) | 2001-01-18 |
PL328198A1 (en) | 1999-01-18 |
NO983217D0 (en) | 1998-07-13 |
ES2165034T3 (en) | 2002-03-01 |
EA001066B1 (en) | 2000-10-30 |
BR9707303A (en) | 2000-05-02 |
CZ292670B6 (en) | 2003-11-12 |
NO983217L (en) | 1998-09-25 |
TR199801398T2 (en) | 1998-10-21 |
PT876144E (en) | 2002-04-29 |
DE19780042D2 (en) | 1999-01-28 |
HUP9901639A3 (en) | 2000-10-30 |
NZ330198A (en) | 2000-06-23 |
CA2244085C (en) | 2008-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999063826A3 (en) | Agents for combating plant pests | |
ZA95631B (en) | Prolineamide derivatives | |
CA2260337A1 (en) | Therapeutic agents | |
IL136044A (en) | 2-aminoacetamide derivatives and pharmaceutical compositions containing the same | |
LU91563I2 (en) | Combinaisson comprising aliskiren, as baselibre or as a pharmaceutically acceptable salt thereof, and hydrochlorothiazide or a pharmaceutically acceptable salt thereof-Rasilez HCT | |
WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
WO1999061010A3 (en) | Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound | |
CA2116829A1 (en) | Use of a pregnane derivative | |
AU2149797A (en) | Therapeutic agents for asthma | |
CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
AU6117698A (en) | Antiviral agents | |
CA2192822A1 (en) | Use of immunosuppressive agents for the treatment of schizophrenia | |
WO1992017065A3 (en) | Method of inhibiting fibrosis | |
CA2362211A1 (en) | Benzamide derivatives and medicament containing the same | |
CA2132528A1 (en) | Agent for use as an anti-irritant | |
CA2349452A1 (en) | Therapeutic agents for drug dependence | |
CA2133186A1 (en) | 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient | |
WO2000002877A3 (en) | New pharmaceutically active compounds | |
WO1996033723A3 (en) | Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness | |
AU1067795A (en) | Use of lithium compounds in the treatment and prevention of alzheimer's disease | |
CA2288966A1 (en) | Preventives and remedies for ulcerous colitis and/or crohn's disease | |
IL114646A0 (en) | Method of inhibiting leukotriene biosynthesis | |
AU5714394A (en) | Cephem compounds with antimicrobial activity | |
ZA200205567B (en) | Quaternary ammonium and their use as anti-tussive agent. | |
TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |